HopeStage
Back to all studies
CompletedNCT03807882

Maintenance ECT Compared With Clozapine for Treatment-Resistant Schizophrenia

About this titleRead the official source — NCT03807882
Medication studyAges 18–60India
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
BhubaneswarSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 1, 2019
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
India
Age range
From 18 Years to 60 Years
Official registry ID
NCT03807882
Official title
Show the full official title

Comparison of Maintenance ECT Versus Clozapine on Psychopathology and Cerebral Hemodynamics in Treatment-resistant Schizophrenia: A Randomized Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bhubaneswar

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Clozapine.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies